Advertisement

  • Loading metrics

Open Access

Correction

Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma

  • Erik Koehne,
  • Nina Zander,
  • Miriam Rodi,
  • Jana Held,
  • Wolfgang Hoffmann,
  • Rella Zoleko-Manego,
  • Michael Ramharter,
  • Ghyslain Mombo-Ngoma,
  • Peter G. Kremsner,
  • Andrea Kreidenweiss
  • Article
  • Metrics
  • Comments
  • Media Coverage

There is an error in Table 2. The line shifted some data into the incorrect drug candidates. Please see the correct Table 2 here.

thumbnail
Download:
Table 2. Drug activity against ex vivo adult worms (step 2).

https://doi.org/10.1371/journal.pntd.0010512.t001

Methylene blue, pyronaridine, and praziquantel (positive control) were exposed to the respective concentrations for 7 days (* for 24 h) followed by a 7 days drug wash-out in vitro culture.”No drug” and DMSO were the negative controls. Pooled data obtained from 3 experiments per drug are displayed.

Reference

  1. 1. Koehne E, Zander N, Rodi M, Held J, Hoffmann W, Zoleko-Manego R, et al. (2021) Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma. PLoS Negl Trop Dis 15(6): e0009511. https://doi.org/10.1371/journal.pntd.0009511 pmid:34166393

Citation: Koehne E, Zander N, Rodi M, Held J, Hoffmann W, Zoleko-Manego R, et al. (2022) Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma. PLoS Negl Trop Dis 16(6): e0010512. https://doi.org/10.1371/journal.pntd.0010512

Published: June 2, 2022

Copyright: © 2022 Koehne et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.